What's New

Medical News
& Alerts

Conferences
& Meetings


Other Medical
Resources

Employment
Opportunities

Partnering
Opportunities

Search results for: Doxil
98%DGNews: New Data Indicate DOXIL Is Appropriate First-Line Therapy for Kaposi's Sarcoma
96%DGNews: FDA Grants Full Approval to Doxil (Doxorubicin), Treatment for Progression or Recurrence of Ovarian Cancer
96%DGNews: Study Compares Doxil/Caelyx (Doxorubicin HCL Liposome Injection) to Doxorubicin for First-Line Treatment of Metastatic Breast Cancer
96%DGNews: Doxil (Liposomal Doxorubicin) Shows Potential In Recurrent Ovarian Cancer
96%DGNews: DOXIL Registration-Oriented Clinical Trials for Ovarian Cancer Patients
95%DGNews: Combination Therapy With Doxil (Doxorubicin) Encouraging In Treating Newly Diagnosed Multiple Myeloma Patients
95%DGNews: ASCO: Doxil (Liposomal Doxorubicin) and Hycamtin (Topotecan) Similar in Ovarian Tumor Shrinkage
95%DGNews: Doxil Approved For Refractory Ovarian Cancer
94%DGNews: FDA Advisors Recommend Doxil For Refractory Ovarian Cancer
92%DGNews: FDA Grants Priority Review To Doxil For Refactory Ovarian Cancer
89%DGNews: Positive Results from Combination Trials Build on Bortezomib for Injection Proven Single-Agent Strength in Relapsed Multiple Myeloma
86%DGNews: AACR-NCI-EORTC: Investigative Prodrug Allows for Monthly Chemotherapy in Ovarian Cancer
85%DGNews: ECCO: Platinum Sensitivity Predicts Response to Liposomal Doxorubicin in Women with Recurrent Ovarian Cancer
85%DGNews: IBCC: Pegylated Liposomal Doxorubicin Has Important Clinical Utility in Breast Cancer
84%DGNews: NCCN Updates Multiple Myeloma Guidelines
80%DGNews: SABCS: Caelyx (Doxorubicin Liposome Injection) Well Tolerated by Patients with Advanced Breast Cancer
79%DGNews: Bortezomib in Combination With Liposomal Doxorubicin and Thalidomide Active Salvage Regimen in Relapse or Refractory Multiple Myeloma: Presented at EHA
79%DGNews: European Drug Advisory Committee Recommends CAELYX For Advanced Ovarian Cancer
77%DGNews: Caelyx (Pegylated Liposomal Doxorubicin Hydrochloride) Approved In Europe For Advanced Ovarian Cancer
Enter keywords you wish to find information about:

Search for documents that contain:
any of these words.
this exact phrase.
all of these words.

 

 

This site is maintained by webmaster@pslgroup.com
Please contact us with any comments, problems or bugs.

All contents Copyright (c) 1998 PSL Consulting Group Inc.
all rights reserved.